Pyott's involvement in Pliant Therapeutics shows a deep commitment. Over time, he has adjusted his holdings, especially notable was his stock option grant in 2021 when he was awarded 250,000 options. In 2022, his vested stock significantly increased his wealth...

Pyott's involvement in Pliant Therapeutics shows a deep commitment. Over time, he has adjusted his holdings, especially notable was his stock option grant in 2021 when he was awarded 250,000 options. In 2022, his vested stock significantly increased his wealth with part of his total compensation from various sources adding up to around $4.8 million in vested stock and options. The fluctuation in his stake in the company reflects a robust tie to its performance and growth, solidifying both his financial interest and leadership role in shaping its future direction.